Education
About Us
Working with TipRanks
Follow Us
Science Arts, Inc. (JP:4412)
:4412
Top Page
Science Arts, Inc.
(4412)
Select Model
Select Model
Rating:55Neutral
Price Target:―
Science Arts, Inc. exhibits strong revenue growth but faces challenges with profitability and cash flow. While the technical analysis suggests positive momentum, the valuation metrics highlight significant hurdles. The company needs to improve operational efficiency to leverage its growth potential effectively.
Science Arts, Inc. (4412) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥10.69B
Dividend YieldN/A
Average Volume (3M)86.77K
Price to Earnings (P/E)96.2
Beta (1Y)0.67
Revenue Growth39.61%
EPS GrowthN/A
CountryJP
Employees46
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)9.63
Shares Outstanding8,219,500
10 Day Avg. Volume147,350
30 Day Avg. Volume86,766
Financial Highlights & Ratios
PEG Ratio1.86
Price to Book (P/B)7.58
Price to Sales (P/S)3.05
P/FCF Ratio-77.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Science Arts, Inc. Business Overview & Revenue Model
Company DescriptionScience Arts, Inc. provides cloud services and software products in Japan. It provides Buddycom, a seamless and scalable communication tool that brings team communications together. The company also offers accessories, such as speaker microphones, headsets, PTT buttons, and smartphones with a PTT button through online store. The company serves airline, railway, bus, logistic, security, construction, taxi, energy, broadcast, event, restaurant, retail, apparel, care, real estate, hotel, medical, manufacture, school, and corporate resilience industries. Science Arts, Inc. was incorporated in 2003 and is based in Tokyo, Japan.
How the Company Makes MoneyScience Arts, Inc. generates revenue through the sale of its proprietary scientific instruments and software solutions. The company markets these products to universities, research institutions, and private industries that require advanced tools for scientific research and development. Additionally, Science Arts, Inc. offers consulting services and technical support, creating an additional revenue stream. Strategic partnerships with academic institutions and technology firms also play a crucial role in enhancing its product offerings and expanding its market reach. The company's revenue is influenced by its ability to innovate and stay at the forefront of scientific and technological advancements.
Science Arts, Inc. Financial Statement Overview
Summary
Science Arts, Inc. demonstrates strong revenue growth but struggles with profitability and cash flow sustainability. The balance sheet is robust due to high liquidity, offset by a concerning operating efficiency. The company must address operational inefficiencies to convert revenue growth into profitability and enhance cash flow stability to support long-term growth.Income Statement
The income statement shows a positive revenue growth trend with a CAGR of approximately 17% from 2020 to 2024. However, persistent negative EBIT and net income indicate ongoing operating challenges. Gross profit margins have been relatively stable, but the company has struggled to translate this into net profitability. The EBIT and EBITDA margins remain negative, highlighting efficiency and cost management issues.45
Neutral
Balance Sheet
The balance sheet reflects a strong liquidity position, with substantial cash reserves consistently exceeding total debt. The equity ratio is stable, indicating a solid capital structure. However, the debt-to-equity ratio has fluctuated, and recent increases in liabilities may pose a risk if not controlled. Overall, the company's financial position is stable, with a favorable equity buffer.60
Neutral
Cash Flow
Cash flow analysis reveals inconsistent free cash flow, affected by volatile operating cash flow and high capital expenditures. There has been a substantial improvement in operating cash flow from a significant negative figure in 2023 to a positive one in 2024, but free cash flow remains negative. The operating cash flow to net income ratio has improved, yet challenges in generating sustainable free cash flow persist.50
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.47B | 1.18B | 771.86M | 659.99M | 365.99M | 222.76M |
| Gross Profit | 907.78M | 677.77M | 490.24M | 435.36M | 265.26M | 166.50M |
| EBITDA | 75.64M | -18.74M | -51.64M | 15.30M | -93.55M | -88.66M |
| Net Income | 39.34M | -31.85M | -81.34M | 9.01M | -95.29M | -92.06M |
Balance Sheet | ||||||
| Total Assets | 1.98B | 953.46M | 894.09M | 801.13M | 351.35M | 428.03M |
| Cash, Cash Equivalents and Short-Term Investments | 1.52B | 562.34M | 504.76M | 663.91M | 260.53M | 373.59M |
| Total Debt | 72.68M | 89.02M | 0.00 | 0.00 | 0.00 | 64.83M |
| Total Liabilities | 660.09M | 477.00M | 385.68M | 230.52M | 117.88M | 149.43M |
| Stockholders Equity | 1.32B | 476.56M | 508.41M | 570.61M | 233.46M | 278.60M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -46.38M | -87.88M | 95.79M | -98.44M | -92.70M |
| Operating Cash Flow | 0.00 | 1.15M | -66.92M | 114.25M | -97.69M | -92.42M |
| Investing Cash Flow | 0.00 | -32.58M | -107.13M | -34.65M | -691.00K | 210.00K |
| Financing Cash Flow | 0.00 | 89.02M | 14.90M | 323.79M | -14.68M | 64.48M |
Science Arts, Inc. Technical Analysis
Negative
1322.00
Price Trends
1393.78
Negative
1280.14
Positive
992.77
Positive
Market Momentum
14.94
Positive
43.52
Neutral
42.92
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4412, the sentiment is Negative. The current price of 1322 is below the 20-day moving average (MA) of 1427.55, below the 50-day MA of 1393.78, and above the 200-day MA of 992.77, indicating a neutral trend. The MACD of 14.94 indicates Positive momentum. The RSI at 43.52 is Neutral, neither overbought nor oversold. The STOCH value of 42.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4412.
Science Arts, Inc. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥8.20B | 16.23 | ― | ― | -0.29% | -20.81% | |
73 Outperform | ¥11.08B | 30.80 | ― | 2.73% | 13.71% | -48.11% | |
67 Neutral | ¥10.10B | 43.83 | ― | 0.35% | 41.69% | 365.14% | |
66 Neutral | ¥12.56B | 16.67 | ― | 0.62% | 12.09% | 141.99% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥20.64B | 22.28 | ― | 0.65% | ― | ― | |
55 Neutral | ¥10.69B | 96.17 | ― | ― | 39.61% | ― |
* Technology Sector Average
JP:4412
Science Arts, Inc.
1,322.00
734.00
124.83%
JP:3853
Asteria Corporation
1,230.00
718.28
140.37%
JP:4019
Stamen Co., Ltd.
1,151.00
275.72
31.50%
JP:4074
LaKeel,Inc
1,069.00
-112.00
-9.48%
JP:4168
Yappli, Inc.
968.00
255.45
35.85%
JP:4193
Fabrica Holdings Co.Ltd.
2,024.00
220.38
12.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.